Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand.

Source:http://linkedlifedata.com/resource/pubmed/id/19535642

J. Immunol. 2009 Jul 1 183 1 696-705

Download in:

View as

General Info

PMID
19535642